» Articles » PMID: 29159062

Evaluation of Factors Influencing F-FET Uptake in the Brain

Overview
Journal Neuroimage Clin
Publisher Elsevier
Specialties Neurology
Radiology
Date 2017 Nov 22
PMID 29159062
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

PET using the amino-acid O-(2-F-fluoroethyl)-l-tyrosine (F-FET) is gaining increasing interest for brain tumour management. Semi-quantitative analysis of tracer uptake in brain tumours is based on the standardized uptake value (SUV) and the tumour-to-brain ratio (TBR). The aim of this study was to explore physiological factors that might influence the relationship of SUV of F-FET uptake in various brain areas, and thus affect quantification of F-FET uptake in brain tumours. Negative F-FET PET scans of 107 subjects, showing an inconspicuous brain distribution of F-FET, were evaluated retrospectively. Whole-brain quantitative analysis with Statistical Parametric Mapping (SPM) using parametric SUV PET images, and volumes of interest (VOIs) analysis with fronto-parietal, temporal, occipital, and cerebellar SUV background areas were performed to study the effect of age, gender, height, weight, injected activity, body mass index (BMI), and body surface area (BSA). After multivariate analysis, female gender and high BMI were found to be two independent factors associated with increased SUV of F-FET uptake in the brain. In women, SUV of F-FET uptake in the brain was 23% higher than in men (p < 0.01). SUV of F-FET uptake in the brain was positively correlated with BMI (r = 0.29; p < 0.01). The influence of these factors on SUV of F-FET was similar in all brain areas. In conclusion, SUV of F-FET in the normal brain is influenced by gender and weakly by BMI, but changes are similar in all brain areas.

Citing Articles

Assessment of Brain Tumour Perfusion Using Early-Phase F-FET PET: Comparison with Perfusion-Weighted MRI.

Filss C, Cramer J, Loher S, Lohmann P, Stoffels G, Stegmayr C Mol Imaging Biol. 2023; 26(1):36-44.

PMID: 37848641 PMC: 10827807. DOI: 10.1007/s11307-023-01861-2.


Sex-specific radiomic features of L-[S-methyl-C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictability.

Papp L, Rasul S, Spielvogel C, Krajnc D, Poetsch N, Woehrer A Front Oncol. 2023; 13:986788.

PMID: 36816966 PMC: 9936222. DOI: 10.3389/fonc.2023.986788.


The Poly I:C maternal immune stimulation model shows unique patterns of brain metabolism, morphometry, and plasticity in female rats.

Casquero-Veiga M, Lamanna-Rama N, Romero-Miguel D, Rojas-Marquez H, Alcaide J, Beltran M Front Behav Neurosci. 2023; 16:1022622.

PMID: 36733452 PMC: 9888250. DOI: 10.3389/fnbeh.2022.1022622.


Use of multimodality imaging, histology, and treatment feasibility to characterize a transgenic -null rat model of glioblastoma.

Jackson L, Masi M, Selman B, Sandusky G, Zarrinmayeh H, Das S Front Oncol. 2022; 12:939260.

PMID: 36483050 PMC: 9722958. DOI: 10.3389/fonc.2022.939260.


A systematic review of amino acid PET in assessing treatment response to temozolomide in glioma.

Prather K, ONeal C, Westrup A, Tullos H, Hughes K, Conner A Neurooncol Adv. 2022; 4(1):vdac008.

PMID: 35300149 PMC: 8923003. DOI: 10.1093/noajnl/vdac008.


References
1.
Weber W, Grosu A, Czernin J . Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning. Nat Clin Pract Oncol. 2008; 5(3):160-70. DOI: 10.1038/ncponc1041. View

2.
Weber D, Zilli T, Buchegger F, Casanova N, Haller G, Rouzaud M . [(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma. Radiat Oncol. 2008; 3:44. PMC: 2628662. DOI: 10.1186/1748-717X-3-44. View

3.
Yoshii F, Barker W, Chang J, Loewenstein D, Apicella A, Smith D . Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy, and cerebrovascular risk factors. J Cereb Blood Flow Metab. 1988; 8(5):654-61. DOI: 10.1038/jcbfm.1988.112. View

4.
Calcagni M, Galli G, Giordano A, Taralli S, Anile C, Niesen A . Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy. Clin Nucl Med. 2011; 36(10):841-7. DOI: 10.1097/RLU.0b013e3182291b40. View

5.
Rota Kops E, Herzog H, Jon Shah N . Comparison template-based with CT-based attenuation correction for hybrid MR/PET scanners. EJNMMI Phys. 2015; 1(Suppl 1):A47. PMC: 4544616. DOI: 10.1186/2197-7364-1-S1-A47. View